Galaxy Surfactants grants 8,400 stock options under PSOP 2025
Galaxy Surfactants Limited's NRC approved the grant of 8,400 stock options under PSOP 2025 at an exercise price of ₹10 per share. Vesting is subject to performance criteria and will occur after the AGM for FY 2028-29, with a four-year exercise window post-vesting.

*this image is generated using AI for illustrative purposes only.
Galaxy Surfactants Limited's Nomination and Remuneration Committee (NRC) approved the grant of 8,400 stock options to eligible employees under the Galaxy Surfactants Limited – Performance Stock Option Plan 2025 (PSOP 2025). The approval was granted during a meeting held on July 22, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The grant allows eligible employees to purchase equity shares, with each stock option carrying the right to apply for and be allotted one equity share with a face value of ₹10. The exercise price for these options has been set at ₹10. The scheme is compliant with the SEBI (Share Based Employee Benefits) Regulations, 2021.
Vesting of these options is contingent upon the achievement of performance criteria decided by the NRC and the continuation of employment. As of the grant date, no options have vested. The vesting is scheduled to occur after the Annual General Meeting for the Financial Year 2028-29. Once vested, the options must be exercised within a period of four years from the date of vesting; failure to do so will result in the lapse of the options.
The disclosure regarding the grant was submitted to the National Stock Exchange of India Ltd. and BSE Limited. The filing confirms that no options have been exercised or lapsed as of the current date. The maximum number of options that grantees may be entitled to under the Galaxy PSOP 2025 Scheme is 157,383.
Key Details of the Grant
| Particulars | Details |
|---|---|
| Options Granted | 8,400 |
| Face Value per Share | ₹10 |
| Exercise Price | ₹10 |
| Vesting Schedule | After AGM for FY 2028-29 |
| Exercise Period | Within 4 years from vesting |
Historical Stock Returns for Galaxy Surfactants
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.06% | -1.53% | -1.41% | +1.15% | -24.29% | -37.78% |
What specific performance criteria has the NRC established to determine the vesting of these options?
How will the issuance of these stock options impact Galaxy Surfactants' earnings per share and shareholder equity?
Is the company planning to expand the Galaxy PSOP 2025 Scheme to include more employees in the future?


































